What is Rapport Therapeutics, Inc.'s non-cash lease expense?

Rapport Therapeutics, Inc. (RAPP) reported non-cash lease expense of $582K in Q1 2026.

How has Rapport Therapeutics, Inc.'s non-cash lease expense changed year-over-year?

Rapport Therapeutics, Inc.'s non-cash lease expense increased by 41.6% year-over-year, from $411K to $582K.

What does non-cash lease expense mean?

Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.

Rapport Therapeutics, Inc. RAPP Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

Supernus PharmaceuticalsSUPN

$2.26M+68.4%

Xenon PharmaceuticalsXENE

$338K+5.0%

Praxis Precision Medicines, Inc.PRAX

$197K-20.9%

Taysha Gene Therapies, Inc.TSHA

$285K-15.9%

Roivant SciencesROIV

$1.86M-5.5%

Crinetics PharmaceuticalsCRNX

$703K-13.5%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.91B+309%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s non-cash lease expense?: Rapport Therapeutics, Inc. (RAPP) reported non-cash lease expense of $582K in Q1 2026.
How has Rapport Therapeutics, Inc.'s non-cash lease expense changed year-over-year?: Rapport Therapeutics, Inc.'s non-cash lease expense increased by 41.6% year-over-year, from $411K to $582K.
What does non-cash lease expense mean?: Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.